tradingkey.logo

Crispr Therapeutics And Sirius Therapeutics Announce Multi-Target Collaboration To Develop Novel Sirna Therapies

ReutersMay 19, 2025 8:53 PM

CRISPR Therapeutics AG CRSP.BN:

  • CRISPR THERAPEUTICS AND SIRIUS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO DEVELOP NOVEL SIRNA THERAPIES

  • CRISPR THERAPEUTICS AG: WILL MAKE AN UPFRONT PAYMENT OF $25 MILLION IN CASH AND $70 MILLION IN EQUITY TO SIRIUS THERAPEUTICS

  • CRISPR THERAPEUTICS AG: ALSO HAS RIGHTS TO EXCLUSIVELY LICENSE UP TO TWO ADDITIONAL SIRNA PROGRAMS

  • CRISPR THERAPEUTICS AG - SRSD107 SHOWS >93% FXI REDUCTION IN PHASE 1 TRIAL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI